Exhibit 5.1
| | |
| | mwe.com |
| Tracy A. Bacigalupo Attorney at Law tbacigalupo@mwe.com +1 212 547 5656 |
May 21, 2021
ACRES COMMERCIAL CAPITAL CORP.
865 Merrick Avenue, Suite 200 S
Westbury, New York 11590
| Re: | Registration Statement on Form S-3 |
Ladies and Gentlemen:
We serve as special Maryland counsel to ACRES Commercial Capital Corp., a Maryland corporation (the “Company”), in connection with the sale and issuance by the Company of up to 2,760,000 shares (the “Shares”) of 7.875% Series D Cumulative Redeemable Preferred Stock, $0.001 par value per share, of the Company (“Series D Preferred Stock”), pursuant to the Underwriting Agreement, dated May 14, 2021 (the “Underwriting Agreement”), by and among the Company, ACRES Capital, LLC, a New York limited liability company, and Raymond James & Associates, Inc., for itself and as Representative of the several Underwriters named in Exhibit A thereto. This opinion is being provided at your request in connection with the filing of the Prospectus Supplement (as defined below).
In connection with our representation of the Company, and as a basis for the opinion hereinafter set forth, we have examined originals, or copies certified or otherwise identified to our satisfaction, of the following documents (collectively, the “Documents”):
1. The Registration Statement on Form S-3 (the “Registration Statement”) relating to the Shares (File Number 333-254315), in the form in which it was filed with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “1933 Act”);
2. The Prospectus dated April 20, 2021, which forms part of the Registration Statement, as supplemented by the Prospectus Supplement dated May 14, 2021 relating to the Shares (the “Prospectus Supplement”), in the forms in which they were filed with the Commission under the 1933 Act;
3. The charter of the Company (the “Charter”), certified as of a recent date by the State Department of Assessments and Taxation of Maryland;
4. The Bylaws of the Company (the “Bylaws”), certified as of the date hereof by the Secretary of the Company;
5. Resolutions adopted by the Board of Directors of the Company (the “Board”) relating to (a) the registration, sale and issuance of the Shares; and (b) the creation and delegation of authority to a Pricing Committee of the Board in connection with the sale and issuance of the Shares (the “Pricing Committee”), certified as of the date hereof by the Secretary of the Company;
| | |
| | 340 Madison Avenue New York NY 10173-1922 Tel +1 212 547 5400 Fax +1 212 547 5444 US practice conducted through McDermott Will & Emery LLP. |